secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2026-08-06T20:05:28+00:00
Accession:  0001193125-26-337953
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q2 revenue $31.6M (+1% YoY); signs $40M HCA refresh deal
-----------------------------------------------------------------------

- Net revenue $31.6M, up 1% YoY and 14% sequentially; recurring revenue $22.1M flat.
- Gross margin 42% (+400 bps YoY); net loss $18.0M vs $18.5M prior year.
- Signed three-year, $40M agreement with HCA Healthcare to refresh Tablo fleet.
- Cash position $151M; net cash used $9.5M in quarter.
- Reiterated FY2026 revenue guidance $125M-$130M (5-9% growth).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000119312526337953/0001193125-26-337953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000119312526337953/om-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-337953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer